
Patricia L. Morris
Examiner (ID: 9557)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1209, 1625, 1612, 1203, 1201 |
| Total Applications | 3798 |
| Issued Applications | 2699 |
| Pending Applications | 142 |
| Abandoned Applications | 965 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4765679
[patent_doc_number] => 20080176891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'NOVEL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 11/858144
[patent_app_country] => US
[patent_app_date] => 2007-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 70778
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20080176891.pdf
[firstpage_image] =>[orig_patent_app_number] => 11858144
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/858144 | NOVEL COMPOUNDS | Sep 19, 2007 | Abandoned |
Array
(
[id] => 6616487
[patent_doc_number] => 20100099718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'PYRIDINE DERIVATIVE SUBSTITUTED BY HETEROARYL RING, AND ANTIFUNGAL AGENT COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/442293
[patent_app_country] => US
[patent_app_date] => 2007-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46625
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099718.pdf
[firstpage_image] =>[orig_patent_app_number] => 12442293
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/442293 | Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same | Sep 19, 2007 | Issued |
Array
(
[id] => 6306090
[patent_doc_number] => 20100069242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Novel-Crystalline Modification Of 4-(N-Methyl-Z-Chloro-5Pyridy Methylamino)-2, 5-Dihydrofuran-2-ON'
[patent_app_type] => utility
[patent_app_number] => 12/441763
[patent_app_country] => US
[patent_app_date] => 2006-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12152
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20100069242.pdf
[firstpage_image] =>[orig_patent_app_number] => 12441763
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/441763 | Crystalline modification of 4-(N-methyl-Z-chloro-5pyridy methylamino)-2, 5-dihydrofuran-2-on | Sep 17, 2007 | Issued |
Array
(
[id] => 6321501
[patent_doc_number] => 20100113524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety'
[patent_app_type] => utility
[patent_app_number] => 12/310868
[patent_app_country] => US
[patent_app_date] => 2007-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9902
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113524.pdf
[firstpage_image] =>[orig_patent_app_number] => 12310868
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/310868 | Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety | Sep 14, 2007 | Abandoned |
Array
(
[id] => 6296296
[patent_doc_number] => 20100240620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => '3-Cyano-5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases'
[patent_app_type] => utility
[patent_app_number] => 12/442399
[patent_app_country] => US
[patent_app_date] => 2007-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18764
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20100240620.pdf
[firstpage_image] =>[orig_patent_app_number] => 12442399
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/442399 | 3-cyano 5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases | Sep 7, 2007 | Issued |
Array
(
[id] => 4949992
[patent_doc_number] => 20080306118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Process for the crystallization of (R) - or (S) - Lansoprazole'
[patent_app_type] => utility
[patent_app_number] => 11/899918
[patent_app_country] => US
[patent_app_date] => 2007-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14658
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20080306118.pdf
[firstpage_image] =>[orig_patent_app_number] => 11899918
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/899918 | Process for the crystallization of (R) - or (S) - Lansoprazole | Sep 6, 2007 | Abandoned |
Array
(
[id] => 4705354
[patent_doc_number] => 20080064878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'PROCESS FOR PRODUCING 1-PYRIDIN-4-YL-INDOLES'
[patent_app_type] => utility
[patent_app_number] => 11/851646
[patent_app_country] => US
[patent_app_date] => 2007-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5223
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064878.pdf
[firstpage_image] =>[orig_patent_app_number] => 11851646
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/851646 | PROCESS FOR PRODUCING 1-PYRIDIN-4-YL-INDOLES | Sep 6, 2007 | Abandoned |
Array
(
[id] => 6605434
[patent_doc_number] => 20100063108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'Pyridin-4-yl derivatives as immunomodulating agents'
[patent_app_type] => utility
[patent_app_number] => 12/310801
[patent_app_country] => US
[patent_app_date] => 2007-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35752
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20100063108.pdf
[firstpage_image] =>[orig_patent_app_number] => 12310801
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/310801 | Pyridin-4-yl derivatives as immunomodulating agents | Sep 5, 2007 | Issued |
Array
(
[id] => 4933671
[patent_doc_number] => 20080004446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'Novel process to prepare pioglitazone via several novel intermediates'
[patent_app_type] => utility
[patent_app_number] => 11/896911
[patent_app_country] => US
[patent_app_date] => 2007-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19177
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20080004446.pdf
[firstpage_image] =>[orig_patent_app_number] => 11896911
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/896911 | Process to prepare pioglitazone via several novel intermediates | Sep 5, 2007 | Issued |
Array
(
[id] => 6550126
[patent_doc_number] => 20100016594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'PROCESS FOR THE PREPARATION OF CLOPIDOGREL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS'
[patent_app_type] => utility
[patent_app_number] => 12/439642
[patent_app_country] => US
[patent_app_date] => 2007-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2602
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20100016594.pdf
[firstpage_image] =>[orig_patent_app_number] => 12439642
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/439642 | Process for the preparation of clopidogrel and its pharmaceutically acceptable salts | Sep 3, 2007 | Issued |
Array
(
[id] => 6424300
[patent_doc_number] => 20100168060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'SALTS OF BENZIMIDAZOLYL PYRIDYL ETHERS AND FORMULATIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/377901
[patent_app_country] => US
[patent_app_date] => 2007-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18149
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168060.pdf
[firstpage_image] =>[orig_patent_app_number] => 12377901
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/377901 | Salts of benzimidazolyl pyridyl ethers and formulations thereof | Aug 29, 2007 | Issued |
Array
(
[id] => 9311891
[patent_doc_number] => 08653109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-18
[patent_title] => 'Substituted bipyridine derivatives and their use as adenosine receptor ligands'
[patent_app_type] => utility
[patent_app_number] => 12/440423
[patent_app_country] => US
[patent_app_date] => 2007-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24014
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12440423
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/440423 | Substituted bipyridine derivatives and their use as adenosine receptor ligands | Aug 29, 2007 | Issued |
Array
(
[id] => 5447081
[patent_doc_number] => 20090048307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => '5-pyridyl-1, 3-azole compounds, process for producing the same and use there of'
[patent_app_type] => utility
[patent_app_number] => 11/896072
[patent_app_country] => US
[patent_app_date] => 2007-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37693
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20090048307.pdf
[firstpage_image] =>[orig_patent_app_number] => 11896072
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/896072 | 5-pyridyl-1, 3-azole compounds, process for producing the same and use there of | Aug 28, 2007 | Abandoned |
Array
(
[id] => 5231575
[patent_doc_number] => 20070293683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 11/845946
[patent_app_country] => US
[patent_app_date] => 2007-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7592
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20070293683.pdf
[firstpage_image] =>[orig_patent_app_number] => 11845946
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/845946 | N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES | Aug 27, 2007 | Abandoned |
Array
(
[id] => 6307415
[patent_doc_number] => 20100069436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'IMIDAZOLE COMPOUNDS HAVING AN ANTIINFLAMMATORY EFFECT'
[patent_app_type] => utility
[patent_app_number] => 12/310305
[patent_app_country] => US
[patent_app_date] => 2007-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29406
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20100069436.pdf
[firstpage_image] =>[orig_patent_app_number] => 12310305
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/310305 | IMIDAZOLE COMPOUNDS HAVING AN ANTIINFLAMMATORY EFFECT | Aug 23, 2007 | Abandoned |
Array
(
[id] => 8028639
[patent_doc_number] => 08143406
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-27
[patent_title] => 'Process for the manufacture of HI-6 dimethanesulfonate'
[patent_app_type] => utility
[patent_app_number] => 12/438643
[patent_app_country] => US
[patent_app_date] => 2007-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3522
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/143/08143406.pdf
[firstpage_image] =>[orig_patent_app_number] => 12438643
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/438643 | Process for the manufacture of HI-6 dimethanesulfonate | Aug 21, 2007 | Issued |
Array
(
[id] => 252841
[patent_doc_number] => 07579475
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-25
[patent_title] => 'S-(-)-amlodipine nicotinate and process for the preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 11/842602
[patent_app_country] => US
[patent_app_date] => 2007-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 3061
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/579/07579475.pdf
[firstpage_image] =>[orig_patent_app_number] => 11842602
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/842602 | S-(-)-amlodipine nicotinate and process for the preparation thereof | Aug 20, 2007 | Issued |
Array
(
[id] => 5231437
[patent_doc_number] => 20070293545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 11/840954
[patent_app_country] => US
[patent_app_date] => 2007-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 126380
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20070293545.pdf
[firstpage_image] =>[orig_patent_app_number] => 11840954
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/840954 | ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | Aug 17, 2007 | Abandoned |
Array
(
[id] => 4803645
[patent_doc_number] => 20080015234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 11/840952
[patent_app_country] => US
[patent_app_date] => 2007-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 126930
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20080015234.pdf
[firstpage_image] =>[orig_patent_app_number] => 11840952
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/840952 | ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | Aug 17, 2007 | Abandoned |
Array
(
[id] => 4670511
[patent_doc_number] => 20080045571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 11/840953
[patent_app_country] => US
[patent_app_date] => 2007-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 126703
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20080045571.pdf
[firstpage_image] =>[orig_patent_app_number] => 11840953
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/840953 | ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | Aug 17, 2007 | Abandoned |